Cardiology overview electrophysiology: Difference between revisions
Jump to navigation
Jump to search
| Line 16: | Line 16: | ||
===Anticoagulation=== | ===Anticoagulation=== | ||
* Patients with a [[CHADS2 score]] of two or higher should be anticoagulated with [[warfarin]]. Some clinicians believe that any patient with [[congestive heart failure]] should also be anticoagulated with [[warfarin]]. | * Patients with a [[CHADS2 score]] of two or higher should be anticoagulated with [[warfarin]]. Some clinicians believe that any patient with [[congestive heart failure]] should also be anticoagulated with [[warfarin]]. | ||
=Anticoagulation based on the CHADS<sub>2</sub> score == | |||
The following treatment strategies are recommended in the table below entitled Anticoagulation based on the CHADS2 score:<ref name="pmid15477396 " /><ref name=Gage2001 /> | |||
{| class="wikitable" style = "float: right; margin-left:15px; text-align:center" | |||
|- | |||
! Score | |||
! Risk | |||
! Anticoagulation Therapy | |||
! Considerations | |||
|- | |||
| '''0''' | |||
| Low | |||
| [[Aspirin]] | |||
| Aspirin daily | |||
|- | |||
| '''1''' | |||
| Moderate | |||
| Aspirin or Warfarin | |||
| Aspirin daily or [[International normalized ratio|INR]] to 2.0-3.0, depending on factors such as patient preference | |||
|- | |||
| '''2 or greater''' | |||
| Moderate or High | |||
| [[Warfarin]] | |||
| [[International normalized ratio|INR]] to 2.0-3.0, unless contraindicated (e.g. clinically significant GI bleeding, inability to obtain regular INR screening) | |||
|} | |||
===Rate Control vs Rhythm Control=== | ===Rate Control vs Rhythm Control=== | ||
Revision as of 20:32, 31 October 2011
|
Cardiology Overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Brugada syndrome
- The Brugada syndrome manifests as ST elevation with a right bundle branch pattern in the right precordial leads. Is treated with implantation of an AICD.
STEMI and Arrhythmias
Implantable Cardiac Defibrillator
- Should not be implanted within 40 days of STEMI
- A patient should wear a defibrillator vest while awaiting AICD implantation
- Amiodarone improves CV survival but not all cause survival in patients with an LVEF of <40%
Atrial Fibrillation
Cardioversion
- In a patient with new onset atrial fibrillation, an attempt at cardioversion should be made. The patient should be anticoagulated with Coumadin for three weeks before the cardioversion and four weeks after the cardioversion. The anticoagulation after the cardioversion is due to the electrical mechanical dissociation that occurs in these patients.
Anticoagulation
- Patients with a CHADS2 score of two or higher should be anticoagulated with warfarin. Some clinicians believe that any patient with congestive heart failure should also be anticoagulated with warfarin.
Anticoagulation based on the CHADS2 score =
The following treatment strategies are recommended in the table below entitled Anticoagulation based on the CHADS2 score:[1][2]
| Score | Risk | Anticoagulation Therapy | Considerations |
|---|---|---|---|
| 0 | Low | Aspirin | Aspirin daily |
| 1 | Moderate | Aspirin or Warfarin | Aspirin daily or INR to 2.0-3.0, depending on factors such as patient preference |
| 2 or greater | Moderate or High | Warfarin | INR to 2.0-3.0, unless contraindicated (e.g. clinically significant GI bleeding, inability to obtain regular INR screening) |
Rate Control vs Rhythm Control
- Rhythm control offers no benefit over rate control in survival
- Rate control is very important in preventing the tachycardia cardiomyopathy syndrome
- Dronedarone reduces hospitalization for atrial fibrillation by about a quarter
Radiofrequency Ablation
- A complication of radio frequency ablation is left atrial tachycardia or flutter. This complication may itself require treatment.
- Anticoagulation should be continued after radiofrequency ablation.
- In patients who have a rapid ventricular response rate in atrial fibrillation and who develop a tachycardia induced cardiomyopathy, AV junctional ablation can be undertaken with permanent pacemaker placement.